AAAAAA

   
Results: 1-15 |
Results: 15
Homocysteine in postmenopausal women and the importance of hormone replacement therapy
Authors: Mijatovic, V van der Mooren, MJ
Citation: V. Mijatovic et Mj. Van Der Mooren, Homocysteine in postmenopausal women and the importance of hormone replacement therapy, CLIN CH L M, 39(8), 2001, pp. 764-767
Perspectives in hormone replacement therapy
Authors: Kenemans, P van Unnik, GA Mijatovic, V van der Mooren, MJ
Citation: P. Kenemans et al., Perspectives in hormone replacement therapy, MATURITAS, 38, 2001, pp. S41-S48
Receptor selectivity, enzymes and tissue specificity
Authors: Mijatovic, V
Citation: V. Mijatovic, Receptor selectivity, enzymes and tissue specificity, MATURITAS, 37(3), 2001, pp. 147-149
Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women
Authors: Kessel, H Kamp, O Kenemans, P Mijatovic, V van Baal, WM Visser, CA van der Mooren, MJ
Citation: H. Kessel et al., Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women, AM J OBST G, 184(5), 2001, pp. 910-916
"Postmenopausal hormone therapy and coronary heart disease - clinical implications of recent randomized trial results" by Leon Speroff - Published in: Maturitas 2000;35 : 91-97 - Comment by V. Mijatovic, Amsterdam (The Netherlands)
Authors: Mijatovic, V
Citation: V. Mijatovic, "Postmenopausal hormone therapy and coronary heart disease - clinical implications of recent randomized trial results" by Leon Speroff - Published in: Maturitas 2000;35 : 91-97 - Comment by V. Mijatovic, Amsterdam (The Netherlands), MATURITAS, 35(2), 2000, pp. 104-105
Menopause, oestrogens, SERM's and cardiovascular health in women
Authors: Mijatovic, V van der Mooren, MJ
Citation: V. Mijatovic et Mj. Van Der Mooren, Menopause, oestrogens, SERM's and cardiovascular health in women, EUR J OB GY, 93(1), 2000, pp. 5-7
Postmenopausal oestradiol-dydrogesterone therapy favourably affects fibrinolysis and Lp(a) in healthy women
Authors: Mijatovic, V Kenemans, P van der Mooren, MJ Emeis, JJ van Baal, WM Peters-Muller, ER Stehouwer, CDA
Citation: V. Mijatovic et al., Postmenopausal oestradiol-dydrogesterone therapy favourably affects fibrinolysis and Lp(a) in healthy women, FIBRINOL PR, 13(4-5), 1999, pp. 177-183
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women - A 2-year, placebo-controlled study
Authors: de Valk-de Roo, GW Stehouwer, CDA Meijer, P Mijatovic, V Kluft, C Kenemans, P Cohen, F Watts, S Netelenbos, C
Citation: Gw. De Valk-de Roo et al., Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women - A 2-year, placebo-controlled study, ART THROM V, 19(12), 1999, pp. 2993-3000
Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: A randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens
Authors: Mijatovic, V van der Mooren, MJ Kenemans, P de Walk-de Roo, GW Netelenbos, C
Citation: V. Mijatovic et al., Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: A randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens, MENOPAUSE, 6(2), 1999, pp. 134-137
The effect of various hormonal preparations and calcium supplementation onbone mass in early menopause. Is there a predictive value for the initial bone density and body weight?
Authors: Pines, A Katchman, H Villa, Y Mijatovic, V Dotan, I Levo, Y Ayalon, D
Citation: A. Pines et al., The effect of various hormonal preparations and calcium supplementation onbone mass in early menopause. Is there a predictive value for the initial bone density and body weight?, J INTERN M, 246(4), 1999, pp. 357-361
L-Thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism
Authors: Pines, A Dotan, I Tabori, U Villa, Y Mijatovic, V Levo, Y Ayalon, D
Citation: A. Pines et al., L-Thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism, GYNECOL END, 13(3), 1999, pp. 196-201
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
Authors: Mijatovic, V van der Mooren, MJ Stehouwer, CDA Netelenbos, JC Kenemans, P
Citation: V. Mijatovic et al., Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection, GYNECOL END, 13(2), 1999, pp. 130-144
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study
Authors: Schutter, EMJ Mijatovic, V Kok, A Van Kamp, GJ Verstraeten, R Verheijen, RHM
Citation: Emj. Schutter et al., Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study, ANTICANC R, 19(6C), 1999, pp. 5551-5557
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
Authors: van Baal, WM Kenemans, P Emeis, JJ Schalkwijk, CG Mijatovic, V van der Mooren, MJ Vischer, UM Stehouwer, CDA
Citation: Wm. Van Baal et al., Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women, FERT STERIL, 71(4), 1999, pp. 663-670
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women
Authors: Mijatovic, V Netelenbos, C van der Mooren, MJ de Valk-de Roo, GW Jakobs, C Kenemans, P
Citation: V. Mijatovic et al., Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women, FERT STERIL, 70(6), 1998, pp. 1085-1089
Risultati: 1-15 |